Reprogenesis' Reverse Merger Round

Reprogenesis raised a round of funding on February 16, 2000. Investors include Curis.

Reprogenesis is a therapeutic drug development company, focusing on regulatory pathways that control repair and regeneration using proteins or small molecules to modulate these pathways.…

Articles about Reprogenesis' Reverse Merger Round: